Home » Healthcare » Pharmaceuticals » Peptic Ulcer Drugs Market

Peptic Ulcer Drugs Market By Drug Class (Antibiotics, Proton Pump Inhibitors (PPLS), H2 Receptor Antagonists, Gastric Mucosal Protective Drugs, Antacids, Prostaglandin Agonists) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Price: $4999

Published: | Report ID: 9131 | Report Format : PDF

Market Insights:

A peptic ulcer is a form of painful sore that develops on the mucosal lining of the stomach, small intestine, or lower esophagus. The global peptic ulcer drugs market is growing due to an increase in the prevalence of H. pylori infection, improved diagnostic techniques, easy availability of treatment medication, preferable use of peptic ulcer medication over surgery, an increase in smocking, and overuse of NSAIDs.

The report titled “Peptic Ulcer Drugs Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall peptic ulcer drugs market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on drug class and different geographical regions.

Geographically, the global peptic ulcer drug market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global peptic ulcer drugs market. In-depth analysis of pipeline molecules for key products in peptic ulcer treatment and global epidemiology data for peptic ulcer have been included in the report.

Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive scenario of the global peptic ulcer drugs market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global peptic ulcer drugs market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global peptic ulcer drugs market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on drug class, the global peptic ulcer drug market is segmented as follows:

  • Antibiotics
  • Proton Pump Inhibitors (PPIs)
  • H2 receptor antagonists
  • Gastric Mucosal Protective Drugs
  • Antacids
  • Prostaglandin Agonists

Peptic ulcers are forms of painful sores that develop on the mucosal lining of the stomach, small intestine, or lower esophagus. Some factors such as an increase in the incidence of H. pylori infections, a change in lifestyles such as stress and diet patterns, an increasing smoking rate, the overuse of NSAIDs such as Naproxen, Ibuprofen, Aspirin, and Ketoprofen, improved diagnostic techniques, and the preferable use of medication over surgery are driving the growth of the peptic ulcer drugs market globally.

For the purpose of the study, the peptic ulcer drugs market is segmented on the basis of drug class, such as antibiotics, proton pump inhibitors (PPIs), H2 receptor antagonists, gastric mucosal protective drugs, antacids, prostaglandin agonists. It is studied that, in the base year 2016, PPIs were a major revenue-generating segment because these drugs are preferably prescribed in the market for the treatment of peptic ulcers caused by H. pylori bacterial infection and NSAIDs. PPIs reduce the amount of acid by blocking the action of the parts of cells that produce acid and prevent further damage.

For the purpose of this study, the global peptic ulcer drugs market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

It is studied that, in the base year 2016, North America dominated the peptic ulcer drugs market in terms of revenue, and it is anticipated that it will show steady growth during the forecast period of 2017–2025. Factors such as a large number of affected people, the higher cost of treatment medication, improved diagnostic techniques, and an increase in funding by government agencies in the healthcare system are driving the growth of the peptic ulcer drugs market in North America.

According to the Centers for Disease Control and Prevention (CDC), peptic ulcer disease is a common illness that affects more than 6 million people in the United States annually. It is observed that currently, Europe is the second largest revenue-generating regional market for peptic ulcer drugs due to the higher number of affected people, improved diagnostic techniques, high healthcare awareness, and overuse of pain medication that are driving market growth in Europe.

The U.K., Germany, and France are major revenue-contributing countries in Europe. It is anticipated that Asia Pacific will show the highest growth rate during the forecast period due to populous countries, developing economic conditions, and improving healthcare infrastructure, which will contribute to market growth in Asia Pacific during the forecast period.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Peptic Ulcer Drugs Market Snapshot
2.2 Global Peptic Ulcer Drugs Market, Drug Class
2.3 Global Peptic Ulcer Drugs Market Share, by Geography, 2016 (Value %)

Chapter 3 Peptic Ulcer Drugs Market Analysis
3.1 Global Peptic Ulcer Drugs Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis in Peptic Ulcer Drugs Market
3.4 Global Epidemiology Data for Peptic Ulcer
3.5 Attractive Investment Proposition
3.6 Competitive Landscape of Key Players in Peptic Ulcer Drugs Market

Chapter 4 Global Peptic Ulcer Drugs Market, by Drug Class
4.1 Overview
4.2 Top 3 Countries
4.3 Antibiotics
4.4 Proton Pump Inhibitors (PPIs)
4.5 H2 Receptor Antagonists
4.6 Gastric Mucosal Protective Drugs
4.7 Antacids
4.8 Prostaglandin Agonists

Chapter 5 Global Peptic Ulcer Drugs Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.2.2 North America Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.3.2 Europe Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.4.1 Asia Pacific Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.5.2 Latin America Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Peptic Ulcer Drugs Market, by Drug Class, 2015- 2025 (US$)
5.6.2 Middle East and Africa Peptic Ulcer Drugs Market, by Country, 2015- 2025 (US$)

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 AstraZeneca plc.
6.3 Cadila Healthcare Ltd.
6.4 Daewoong Pharmaceuticals
6.5 Eisai Co. Ltd.
6.6 PharmaKing Co. Ltd.
6.7 Taiho Pharmaceutical (A Otsuka Holdings)
6.8 Takeda Pharmaceutical
6.9 Yuhan Corporation

List of Figures

FIG. 1 Peptic Ulcer Drugs Market: Research Methodology
FIG. 2 Global Peptic Ulcer Drugs Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Peptic Ulcer Drugs Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Peptic Ulcer Drugs Market, by Geography, 2016
FIG. 5 Global Antibiotics Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)
FIG. 6 Global Proton Pump Inhibitors (PPIs) Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)
FIG. 7 Global H2 Receptor Antagonists Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)
FIG. 8 Global Gastric Mucosal Protective Drugs Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)
FIG. 9 Global Antacids Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)
FIG. 10 Global Prostaglandin Agonists Market in Peptic Ulcer Treatment, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Peptic Ulcer Drugs Market
TABLE 2 Global Peptic Ulcer Drugs Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Peptic Ulcer Drugs Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Peptic Ulcer Drugs Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 5 North America Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 6 North America Peptic Ulcer Drugs Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 Europe Peptic Ulcer Drugs Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Asia Pacific Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 10 Asia Pacific Peptic Ulcer Drugs Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Latin America Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 12 Latin America Peptic Ulcer Drugs Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Middle East and Africa Peptic Ulcer Drugs Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Middle East and Africa Peptic Ulcer Drugs Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Cadila Healthcare Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Daewoong Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Eisai Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 PharmaKing Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 21 Taiho Pharmaceutical (A Otsuka Holdings): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 22 Takeda Pharmaceutical: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Yuhan Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently Asked Question:

What is the size of Peptic Ulcer Drugs Market?

The market for Peptic Ulcer Drugs Market is expected to reach USD$ 5.92 Bn in 2025.

What is the Peptic Ulcer Drugs Market CAGR?

The Peptic Ulcer Drugs Market is expected to see significant CAGR growth over the coming years, at 2.8%.

What is the Forecast period considered for Peptic Ulcer Drugs Market?

The report is forecasted from 2015 -2025.

What is the base year considered for Peptic Ulcer Drugs Market?

The base year of this report is 2014.

Who are the major players in this market?

Abbott Laboratories, Astra Zeneca plc., Cadila Healthcare Ltd., Daewoong Pharmaceuticals. are some of the major players in the global market.

Molecular Transport Medium Market

Published:
Report ID: 35092

Angiotensin Converting Enzyme (ACE) Inhibitors Market

Published:
Report ID: 12832

Stroke Management Market

Published:
Report ID: 34872

Pulmonary Embolism Market

Published:
Report ID: 34866

Oral Macromolecular Formulation Market

Published:
Report ID: 34861

Metastatic Melanoma Cancer Diagnostics Market

Published:
Report ID: 34855

Cytomegalovirus (CMV) Infection Treatment Market

Published:
Report ID: 4417

Immune Checkpoint Inhibitors Market

Published:
Report ID: 34697

Intraosseous Devices Market

Published:
Report ID: 7197

Dermatophytic Onychomycosis Therapeutics Market

Published:
Report ID: 34653

Africa Pharmaceutical Market

Published:
Report ID: 34584

Allergic Rhinitis Treatment Market

Published:
Report ID: 34575

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN